Suggestions
Idioma
Guide for authors
Searcher
Journal Information
Cite
Cite
Share
Download PDF
More article options
Visits
582
Update in Intensive Care
Full text access

Transesophageal echocardiography: A comprehensive assessment of the critically ill patient

Ecocardiografía transesofágica: valoración integral del paciente crítico
Visits
582
Virginia Fraile-Gutiérreza,
Corresponding author
vicky_uvi@yahoo.com

Corresponding author.
, David Pérez-Torresa, Luis Martin-Villenb, Luís Zapatac, Ana Ochagaviad
a Servicio de Medicina Intensiva, Hospital Universitario Río Hortega de Valladolid, Gerencia Regional de Salud de Castilla y León (SACYL), Valladolid, Spain
b UGC Cuidados Intensivos, Hospital Universitario Virgen del Rocío, Seville, Spain
c Servicio Medicina Intensiva, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
d Servicio de Medicina Intensiva, Hospital Universitario de Bellvitge, Calle de la Feixa Llarga, s/n 08907, L’Hospitalet de Llobregat, Barcelona, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (16)
fig0005
fig0010
fig0015
fig0020
fig0025
fig0030
202605040549557281
202605040549557282
202605040549557283
202605040549557284
202605040549557285
202605040549557286
202605040549557287
202605040549557288
202605040549557289
2026050405495572810
Tables (5)
Table 1. Indications and contraindications for TEE in the critically ill patient.
Tables
Table 2. Basic exploration sequence views of TEE in the critically ill patient.
Tables
Table 3. Complementary exploration sequence views of TEE in the critically ill patient.
Tables
Table 4. Echocardiographic study views during cardiopulmonary resuscitation.
Tables
Table 5. Structures and evaluation parameters in the ECMO patient with transesophageal echocardiography.
Tables
Additional material (5)
Abstract

Transesophageal echocardiography (TEE) has become an essential tool in the management of critically ill patients, particularly when transthoracic echocardiography is insufficient. Its use allows to obtain high-quality imaging to assess cardiac function, diagnose the cause of shock, monitor fluid responsiveness, and evaluate venous congestion. It is especially valuable in complex scenarios such as stroke, the postoperative period after cardiac surgery, ECMO support, and during cardiac arrest, as it provides continuous visualization without interrupting chest compressions. Although it is a semi-invasive technique, it has a very favorable safety profile when performed by trained intensivists. Adequate training, including supervision and simulation, is crucial for achieving competence. Besides, TEE allows the examination of pulmonary and abdominal structures, extending its utility beyond the heart. Its incorporation into Intensive Care Medicine has demonstrated significant clinical impact, modifying therapeutic management in a high proportion of patients.

Keywords:
Ultrasonography
Transesophageal echocardiography
Critical care
Hemodynamic monitoring
Shock
Respiratory insufficiency
Cardiac surgical procedures
Extracorporeal membrane oxygenation
Resumen

La ecocardiografía transesofágica (ETE) se ha convertido en una herramienta esencial en el manejo del paciente crítico, especialmente cuando la ecocardiografía transtorácica resulta insuficiente. Su uso permite obtener imágenes de alta calidad para evaluar la función cardíaca, diagnosticar causas de shock, monitorizar la respuesta a fluidos y valorar la congestión venosa. Es especialmente útil en escenarios complejos como el ictus, postoperatorio de cirugía cardíaca, el soporte con ECMO y durante la parada cardiorrespiratoria, ya que ofrece visualización continua sin interrumpir las compresiones. Aunque es una técnica semi-invasiva, presenta un perfil de seguridad muy favorable cuando es realizada por intensivistas entrenados. La formación adecuada, incluyendo supervisión y simulación, es clave para alcanzar competencia. Además, la ETE permite explorar estructuras pulmonares y abdominales, ampliando su utilidad más allá del corazón. Su incorporación en los Servicios de Medicina Intensiva ha demostrado impacto clínico significativo, modificando conductas terapéuticas en un alto porcentaje de pacientes.

Palabras clave:
Ecocardiografía
Ecocardiografía transesofágica
Cuidados críticos
Monitorización hemodinámica
Shock
Insuficiencia respiratoria
Cirugía cardiaca
Oxigenación por membrana extracorpórea
Full Text
The new paradigm of transesophageal echocardiography in Departments of Intensive Care Medicine

Transesophageal echocardiography (TEE) is considered an advanced competence of ultrasound in critically ill patients.1,2 Training in TEE assessment, especially in patients on invasive mechanical ventilation (IMV), requires less professional capacitation than that required in the cardiology imaging laboratory. It can be reasonably achieved within 30−35 supervised scans,2–4 which can be further reduced if simulators are used as part of the training.5

The intensivist is frequently confronted with obstacles that hinder adequate imaging by transthoracic echocardiography (TTE), such as the patient's body type, the presence of wounds, dressings, drains, edema, IMV, or intra-abdominal hypertension.6 When TTE proves insufficient, TEE can provide very valuable anatomical and hemodynamic information through a systematic, goal-directed approach.6,7 TEE offers a unique view of the heart’s structure and function, enabling identification of the circulatory failure mechanisms in complex scenarios such as the postoperative period after cardiac surgery or extracorporeal membrane oxygenation (ECMO). Additionally, TEE provides information on cardiac output (CO), response to fluids, biventricular function, and the presence of severe valvular heart disease. As a procedure, TEE is easy to initiate, reproducible, and less operator-dependent than TTE.8

The popularity of TEE in recent years is due to its greater availability in Departments of Intensive Care Medicine (DICMs). The performance of TEE in critical patients has been associated with changes in treatment in a significant number of cases, reaching 80% in some series9 and up to 40% of cases when performed alongside other advanced hemodynamic monitoring systems.10 These results are maintained when the procedure is performed by supervised trainee physicians.11 TEE findings obtained by intensivists, compared with TTE or TEE performed by cardiologists, show high accuracy for the main diagnoses (90-100%) and other relevant diagnoses (88–100%).12 Together with a very low complication rate,4 all this has led to the consolidation of TEE’s role in DICMs in recent years, as recognized in consensus documents of different European societies.13,14

Indications, contraindications, and safety of the procedure

TEE in the critically ill patient is often performed on intubated individuals with respiratory support, under analgosedation, in an Intensive Care Unit (ICU) or a critical care area with similar medical equipment.11 To ensure the safety of the procedure, it is essential to understand the indications and contraindications of the technique, which are summarized in Table 1.14,15 For patients with relative contraindications, a personalized assessment of the risk-to-benefit ratio should be performed. If the decision is made to perform the procedure, certain precautions should be taken, such as limiting probe manipulation or avoiding advancing the probe beyond the mid-esophageal plane.15

Table 1.

Indications and contraindications for TEE in the critically ill patient.

Indications  Contraindications 
  • Assessment of cardiovascular failure or shock, when TTE proves insufficient

  • Monitoring of the patient in prone position

  • Hypotension of uncertain origin in the postoperative cardiac surgery patient

  • Identification of preload/dependency status

  • Unexplained hypoxemia

  • Identification of aortic dissection

  • Differential diagnosis in cardiac arrest

  • Identification of intracardiac thrombi and evaluation of the heart as a source of systemic embolisms

  • Identification of pulmonary thromboembolism

  • Guidelines for invasive procedures (ECMO, IABC, pacemakers, etc.)

  • Assessment of valve structure and function

  • Suspected mechanical complication following acute myocardial infarction

  • Blunt chest trauma

Absolute: 
  • Anatomical alteration of the esophagus: perforation, stricture, tumor, laceration or diverticulum

  • Active upper gastrointestinal bleeding

 
Relative: 
  • Other esophagogastric anatomical alterations: esophageal varicose veins, Barrett's esophagus, active esophagitis, symptomatic hiatal hernia, peptic ulcer and esophagogastric surgery

  • Recent upper gastrointestinal bleeding

  • Coagulopathy (INR > 4 or aPTT > 150 s) or thrombocytopenia (<50 × 103/µl)

  • Cervical or mediastinal radiotherapy

  • Restricted cervical mobility

  • History of dysphagia or odynophagia

 

IABC: intra-aortic balloon counterpulsation; ECMO: extracorporeal membrane oxygenation; TEE: transesophageal echocardiography; TTE: transthoracic echocardiography.

The main risks of TEE stem from the possibility of mechanical injury to the upper airway or digestive tract during probe insertion and manipulation, as well as from the administration of analgesia and sedation.16 In critically ill patients, the risk of airway injury is significantly reduced when the probe is introduced under direct esophageal visualization using a laryngoscope or videolaryngoscope.17–19 The risks associated with analgesia and sedation are significantly reduced when patients are monitored and receive support from a team of experts in the management of the hemodynamic effects of the drugs used. Despite its semi-invasive nature, TEE in critically ill patients is a safe procedure, with a practically zero incidence of major complications (e.g., death or esophageal perforation), and a low incidence (2.6%) of minor complications (e.g., unintentional nasogastric tube removal, mild bleeding, transient hypotension or hypoxemia, or mild oropharyngeal laceration).20,21

Components and movements of the transesophageal echocardiography probe

The TEE probe consists of a rigid handle connected to a flexible axial shaft, numbered in centimeters. This feature facilitates orientation and safe insertion. The distal end of the shaft contains the transducer lens with piezoelectric crystals, which obtains the image and has multiplanar rotation capability. Probe movements are controlled from the handle using 2 wheels and 2 buttons. Most probes include a locking lever or button that allows the position to be fixed. The transducer handle, in turn, is connected to the ultrasound machine via a cable and connector (Fig. 1A).

Figure 1.

A) TEE probe components. B) TEE probe movements.

The TEE probe requires 4 types of movement for imaging (Fig. 1B)15:

  • The movement of advancing the tip of the transducer to a certain depth in the esophagus or stomach is referred to as "advancement". The opposite movement, i.e., withdrawing the transducer toward the oral cavity, is called "withdrawal".

  • The rotational movement of the transducer within the esophagus, so that the piezoelectric crystal is directed toward the lung or the descending aorta, is called "turning". Turning can be to the right (clockwise) or to the left (counterclockwise).

  • The transducer tip flexes using the control wheels on the handle. The larger wheel controls flexion along the anteroposterior axis, producing "anteflexion" and "retroflexion" movements. These movements guide the ultrasound beam similarly to the tilting movement in TTE. The smaller wheel, in turn, controls flexion along the right/left axis, with "right flexion" and "left flexion" movements. Advancement/withdrawal or right/left turning movements should be performed with the transducer tip in a neutral position (without anteflexion or retroflexion), to reduce the pressure in the esophagus and minimize the risk of injury.

  • The piezoelectric crystal can be rotated from 0° to 180°degrees by means of the multiplanar rotation buttons located on the probe handle. This performs "forward rotation" (increasing degrees) and "backward rotation" (decreasing degrees) movements.

Probe insertion procedure

During the preparation phase, it must be ensured that the patient meets the conditions necessary for a safe and uncomplicated procedure. The patient's well-being and safety must be guaranteed after administering analgesia, sedation, and neuromuscular blockade (the latter if deemed necessary).15 It is advisable to have medication and equipment available to treat potential complications, such as cardiovascular instability or unintentional extubation.

The critically ill patient remains in the supine position during TEE, with the operator positioned at the patient’s side. For insertion, the probe is placed in the neutral position with the lever "unlocked", and water-soluble gel or lubricant is applied to the crystal.15 To ensure the integrity of the probe, it is advisable to insert a bite block between the patient’s dental arches. Then, the probe is introduced with the transducer crystal facing the floor of the mouth under esophageal vision. This reduces the risk of injury to the oropharynx and piriform fossa.18,19 The transducer should be advanced smoothly. Slight resistance might be noted when passing the cricopharyngeal muscle,7 but advancement should not be forced if it is not possible. After advancing 30−35 cm, the four cardiac chambers can be seen in the so-called mid-esophageal 4-chamber (ME-4C) view or plane. It is helpful to have an assistant hold the patient's orotracheal tube to prevent displacement during movement. The ultrasound equipment monitors the probe temperature. The study should be stopped if 40 °C is reached, in order to avoid thermal injury to the esophagus.

Exploration protocol

The exploration protocol in a critically ill patient is markedly different from that used in a cardiac imaging laboratory. Thus, while a standard cardiac exploration should contain at least 28 planes, according to the recommendations of the American Society of Echocardiography (ASE),15 most of the useful information in the critically ill patient can be obtained with shorter protocols of between 11 and 16 planes,22,23 reducing the number of planes used for detailed valvular assessment. Protocols have even been described that simplify image acquisition to only four planes, to prevent the intensivist from focusing on the complexity of the scan (basic versus advanced) and rather centering attention on the image acquisition modality that can best respond to the clinical question and needs of the patient (TTE versus TEE).7

In our experience, a basic 5-plane imaging protocol (ME-4C, ME-LAX, ME-bicava, TG-SAX PM, and dTG-5C), as detailed in Table 2 and Fig. 2, is excellent for becoming familiarized with the technique and answering many questions of interest in the critically ill patient. Intensivists who master this sequence can easily acquire skills to obtain another 5 complementary planes (ME-MC, ME-2C, ME DescAo SAX, ME RV In-Out, and ME AscAo SAX) (Table 3) or perform the intermediate or complete extension protocols described in the literature.15,22,23

Table 2.

Basic exploration sequence views of TEE in the critically ill patient.

2D image  Acquisition protocol  Visualized structures  Systematic interpretation 
Mid-esophageal 4 chambers (ME-4C)Atria 
  • Cavity size

  • Global biventricular function

  • Alterations of segmental contractility

  • Morphology and color Doppler in mitral and tricuspid valves

  • Pericardial effusion

Interatrial septum 
Ventricles 
  • Insert the probe in neutral position to a depth of 30−35 cm, where you will visualize the atria, ventricles and aortic valve

  • Advance and slightly retroflex the probe to hide the aortic valve and correctly visualize the left ventricular apex

  • It may be necessary to adjust the transducer angle to 0−20°

Interventricular septum 
Mitral valve (A3A2 and P2P1
Tricuspid valve (septal and posterior leaflets) 
Mid-esophageal long axis (ME-LAX)Left atrium 
  • Global left ventricular function

  • Alterations of segmental contractility

  • Morphology and color Doppler in mitral and aortic valves

  • Left ventricular outflow tract (diameter measurement, dynamic obstruction)

  • Proximal ascending aorta (dissection, etc.)

Left ventricle 
LV and RV outflow tract 
  • From the anterior plane, adjust the transducer angle to reach 120−140°

  • Note: During transducer angle adjustment, you can visualize the mid-esophageal plane at the level of the mitral commissure (50−70°) and the mid-esophageal 2-chamber (ME-2C) view (80−100°), which may be of interest for assessing additional elements (left atrial appendage, etc.)

Mitral valve (P2–A2
Aortic valve 
Proximal ascending aorta 
Mid-esophageal bicava (ME-bicava)Left atrium 
  • Control of invasive procedures (ECMO cannulation guides, ECMO cannula position, pacemaker implantation, etc.)

  • Assessment of preload/dependence (respiratory variation of the superior vena cava)

  • Detection of interatrial septal defect or patent foramen ovale

Right atrium 
Interatrial septum 
  • From the anterior plane, adjust the transducer angle to reach 90−110°

  • Rotate the probe to the right (clockwise) until you visualize both atria, the interatrial septum, and the superior and inferior venae cavae

Superior vena cava 
Inferior vena cava 
Transgastric short axis at papillary muscle level (TG-SAX PM)LV (middle segments) 
  • Left ventricular size

  • Left ventricular function

  • Ventricular interdependence

  • Alterations of segmental contractility

  • Pericardial effusion

Papillary muscles 
  • From the anterior plane, return to the ME-4C view by turning the probe to the left (counterclockwise), and adjusting the transducer angle to 0°

  • Advance the probe into the stomach until the liver parenchyma is slightly visualized

  • Anteflexion of the probe allows visualization of a plane at the level of the papillary muscles

  • If you visualize the mitral valve, release anteflexion, advance slightly and perform anteflexion again

  • If you visualize the apex, release anteflexion, withdraw slightly and perform anteflexion again

 
VD (middle segments) 
Deep transgastric 5-chambers (dTG-5C)Left ventricle 
  • Morphology and color Doppler in aortic and mitral valves

  • Estimation of stroke volume (VTI, LVOT)

  • Dynamic LVOT obstruction assessment

  • Aortic assessment (stenosis, insufficiency, dissection)

LV outflow tract 
  • From the anterior plane, release anteflexion, advance slowly and, when you reach the apex or slightly exceed it, perform maximum anteflexion

  • It may be necessary to adjust the transducer angle between 0−20° and/or perform slight left flexion

Right ventricle 
Aortic valve, aortic root 
Mitral valve 

ECMO: extracorporeal membrane oxygenation; TEE: transesophageal echocardiography; VTI: velocity-time integral; LVOT: left ventricular outflow tract; RV: right ventricle; LV: left ventricle.

Figure 2.

Basic and complementary sequence of the TEE study in critically ill patients: A) Schematic representation of the basic (yellow) and complementary (gray) sequences for TEE exploration in the critically ill patient. B) Nomenclature and basic anatomy of the views obtained in the basic and complementary exploration sequences.

Table 3.

Complementary exploration sequence views of TEE in the critically ill patient.

2D image  Acquisition protocol  Visualized structures  Systematic interpretation 
Mid-esophageal at the level of the mitral commissure (ME-MC)Left atrium 
  • Cavity size

  • Global left ventricular function

  • Alterations of segmental contractility

  • Morphology, color Doppler and spectral Doppler of the mitral valve

  • Assessment of the papillary muscles

Coronary sinus 
Mitral valve (P3-A3A2A1-P1
  • From the ME-4C plane, adjust the transducer angle to 50−70°

Left ventricle 
Papillary muscles 
Chordae tendineae 
Mid-esophageal 2-chambers (ME-2C)Left atrium 
  • Cavity size

  • Global left ventricular function

  • Alterations of segmental contractility

  • Morphology, color Doppler and spectral Doppler of the mitral valve

  • Left atrial appendage assessment (size, velocity, presence of thrombi, etc.)

Coronary sinus 
Left appendage 
  • From the ME-4C or ME-MC plane, adjust the transducer angle to 80−100°

Mitral valve (P3-A3A2A1
Left ventricle 
Circumflex artery 
Mid-esophageal short axis of descending aorta (ME DescAo SAX)  Descending aorta
  • Morphology of the descending aorta (dissection, intramural hematoma, penetrating ulcer, etc.)

  • Control of invasive procedures (ECMO cannulation guide, etc.)

  • From the ME-4C plane, rotate the transducer counterclockwise until a circular structure (aorta) is visualized

  • It is possible to follow the path of the aorta to the transgastric or upper esophageal level by advancing or withdrawing the probe, respectively, while keeping the aorta in the center of the image

  • A long axis of the aorta can be obtained by adjusting the transducer angle to 90−100° (ME DescAo LAX)

 
Mid-esophageal right ventricle inflow tract - outflow tract (ME RV In-Out)Atria 
  • Morphology of the right ventricular outflow tract

  • Morphology and color Doppler of the aortic, tricuspid and pulmonary valves

Interatrial septum 
Aortic valve 
Right ventricular outflow tract 
  • From the ME-4C plane, slowly withdraw the transducer until the aortic valve is visualized in the center of the image (ME-5C)

  • Anteflex slightly and adjust the transducer angle to 50−70°

Tricuspid valve 
Pulmonary valve 
Pulmonary artery 
Mid-esophageal short axis of ascending aorta (ME AscAo SAX)Ascending aorta 
  • Morphology of the ascending aorta (dissection, etc.)

  • Assessment of preload/dependence (respiratory variation of the superior vena cava)

  • Functional assessment of the pulmonary artery and detection of thrombi

Pulmonary artery 
  • From the ME-4C plane, slowly withdraw the probe visualizing the aortic valve (ME-5C) and continue withdrawing until the ascending aorta, superior vena cava and pulmonary artery are identified

  • It may be necessary to adjust the transducer angle 0−30°

Right pulmonary artery 
Superior vena cava 

ECMO: extracorporeal membrane oxygenation; TEE: transesophageal echocardiography.

Application in specific critical scenariosIdentification of the cause of shock

Obtaining a basic imaging protocol for characterizing a state of shock is one of the main indications for TEE in critically ill patients. The main objective is to identify disorders such as severe left or right ventricular dysfunction, severe valvular heart disease, pericardial effusion, or tamponade. Less frequent causes of shock include dynamic left ventricular outflow tract (LVOT) obstruction or extrinsic cardiac compression.21,24

In patients where the cause of shock is known, TEE can help to assess preload dependence and optimize the dosage of vasoactive and inotropic drugs. Monitoring CO requires measuring the LVOT diameter in mid-systole, in the mid-esophageal long-axis (ME-LAX) plane, and magnifying the image to improve accuracy (Fig. 3A). It also requires quantifying the velocity-time integral (VTI) of the LVOT (Fig. 3B), which is obtained in the deep transgastric 5-chamber (dTG-5C) plane.21,24 The calculation of CO requires averaging three consecutive beats when measuring the LVOT VTI. Estimating CO by TEE has the same limitations as in the case of TTE,25,26 fundamentally due to the assumption that the LVOT is a circumference (when in fact it is an oval), and from the possibility of underestimating or overestimating the measurement (due to deviation from the Doppler alignment axis or approximating the sample volume excessively towards the aortic valve, respectively). Consequently, error can be reduced by using the LVOT VTI exclusively to guide the therapeutic interventions. Additionally, the transvalvular aortic gradient can be assessed in this position. This provides information on flow dynamics and can detect dynamic LVOT obstruction when a dagger-shaped flow is observed (Fig. 3C). It also detects the presence of ascending aortic dissection as the cause of shock (Fig. 3D). Finally, diastolic function can be analyzed by studying the mitral filling pattern with pulsed Doppler in ME-4C.

Figure 3.

Study images of the patient in shock and volume response parameters.

Evaluation of volume response

TEE allows for the acquisition of preload parameters and the prediction of volume response. The presence of kissing walls and left ventricular (LV) obliteration identified in the transgastric short-axis plane at the level of the papillary muscles (TG-SAX PM) suggests severe hypovolemia, especially when associated with an LV end-diastolic area <10 cm2 (or <6 cm2/m2) (Fig. 3E).27

On the other hand, dynamic parameters such as a variation in peak aortic flow velocity in the LVOT > 12%, by pulsed Doppler, have been shown to be a good predictor of volume response in patients on IMV and without arrhythmias.28,29

Respirophasic variation of the superior vena cava (SVC) on its long axis, as measured in the mid-esophageal bicaval (ME-bicava) plane (Fig. 3F), is the most specific echocardiographic predictor of volume response. It surpasses the variation of the inferior vena cava (ΔIVC), the Δ LVOT VTI, and the variation of systolic volume.30–32 Vieillard-Baron et al.33 established a cut-off point of 36% (90% sensitivity [Se] and 100% specificity [Sp]) for Δ  SVC ([diametermax − diametermin]/diametermax × 100) in patients subjected to IMV. A recently published study that included ventilated postoperative patients with tidal volume < 8 ml/kg identified a superior vena cava collapsibility index (SVC-CI) cut-off point Δ of 39.4% (Se 64% and Sp 92%).34 An SVC-CI > 37% on the short axis, obtained in the mid-esophageal ascending aorta short axis plane (ME AscAo SAX), was associated with volume response in postoperative cardiac surgery patients. Measurements obtained in M-mode in the ME-bicaval and ME AscAo SAX planes are taken at different anatomical sites and are therefore not interchangeable.35 Obtaining the ME AscAo SAX view presents less technical difficulty compared to the ME-bicava plane.

Assessment of systemic congestion

The study of systemic venous congestion using ultrasound is very useful for critically ill patients.36 In the context of TEE, information can also be obtained to complete the Venous Excess Ultrasound (VExUS) protocol, although the difficulty may be greater than with the abdominal study.37

The transesophageal VExUS study begins with the evaluation of the diameter of the IVC. From the ME-4C plane, the probe is rotated clockwise to focus on the right atrium (RA), and carefully advanced to visualize the cavoatrial junction, the IVC, and the confluence with the hepatic veins. Alternatively, the IVC can be assessed from the transgastric plane by flexing and rotating the probe clockwise.

The hepatic veins can be observed from both the distal esophageal plane, previously described, and from the transgastric plane. In this case, the probe is anteflexed and directed toward the RA starting at an angle of 0° and progressively adjusting between 0° and 60° (Fig. 4A). Once the vein is identified, the pulsed Doppler sample volume is placed at about 2−3 cm proximal to its confluence with the IVC, to evaluate hepatic blood flow (Fig. 4B).

Figure 4.

VExUS protocol by TEE. IVC: inferior vena cava; HV: suprahepatic vein; PV: portal vein.

Then, the portal vein is visualized from the deep transgastric plane by adjusting the angle between 20° and 60° (Fig. 4C). Color Doppler allows the identification of portal flow, which is directed upwards towards the transducer. The pulsed Doppler is then placed to assess the flow (Fig. 4D).

Although renal evaluation using TEE may be technically demanding in some patients, it is generally possible. Starting from the deep transgastric plane, the probe is rotated approximately 180° degrees until the descending aorta is visualized. Then, it is advanced slightly and rotated counterclockwise until the left kidney is identified (Fig. 4E). Alternatively, the kidney can be visualized in longitudinal section by maintaining a 90° angle and rotating the probe counterclockwise from the short-axis view of the descending aorta. Once the renal structure has been located, the pulsed Doppler is placed over an interlobar artery to record both the arterial and venous flow simultaneously (Fig. 4F).

Differential diagnosis of hypoxemia

In critically ill patients, acute hypoxemia may be due to various cardiopulmonary conditions, so a differential diagnosis must be established quickly and accurately. In this context, TEE has established itself as a valuable diagnostic tool. This technique allows for the simultaneous evaluation of cardiac and pulmonary causes of hypoxemia, with high spatial resolution, independent of lung parenchyma or intestinal gas interference.

In cases of refractory hypoxemia, TEE is particularly useful for ruling out the presence of intracardiac shunts, such as patent foramen ovale (PFO) with a right-to-left shunt. This condition can be observed in patients with acute respiratory distress syndrome (ARDS) who require IMV support.38 For the identification of PFO using TEE, it is advisable to use the ME-bicaval plane, centering the view in the fossa ovalis. Additionally, 9.5 ml of saline mixed with 0.5 ml of room air is injected through two syringes connected to a three-way valve to generate echocontrast (shaken saline microbubbles). The injection is considered successful if the entire RA is opacified by the contrast induced by the microbubbles. A significant PFO is defined as the passage of more than 10 bubbles within three heartbeats after RA opacification (Appendix B Video 1). This test also allows for the detection of intrapulmonary shunts, which are characterized by the late passage (>3 cycles) of bubbles through the pulmonary veins.39

In addition, TEE is useful when pulmonary thromboembolism is suspected, allowing the visualization of indirect signs such as dilatation and dysfunction of the right ventricle (RV) or thrombi located in the right chambers or pulmonary arteries.40 Right ventricular volume or pressure overload is diagnosed by assessing interventricular septal dynamics.41

The introduction of transesophageal lung ultrasound (TELU) has made it possible to expand the technique’s usefulness to analyzing the lung parenchyma, particularly in posterior zones.42 The degree of aeration has been associated with PO2/FiO2 and 28-day mortality.43 Although the technique may be more complicated, the semiology is similar to that of transthoracic ultrasound.44 The study is performed by means of a craniocaudal exploration of each hemithorax. Reference points for the apical, middle, and basal lung zones are identified by the left subclavian artery’s origin, and the left superior pulmonary vein’s origin, and the IVC’s origin, respectively (Fig. 5). From each of these reference points identified with the transducer at 0°, a rotation to 90° allows the lungs to be studied over a longitudinal axis. From the cardiac view, for the study of the left hemithorax, the probe should be rotated counterclockwise, obtaining a view that allows examination of the lung, pleura, diaphragm, spleen, and, occasionally, the left kidney. For the study of the right hemithorax, the probe is rotated clockwise, using the same technique described above, initially with the transducer at 0° and subsequently at 90°. This method explores the right hemithorax, including the pleural space, lung, diaphragm, and underlying liver.

Figure 5.

Protocol for the study of the lung parenchyma by TEE (TELU). PE: pleural effusion.

Care during cardiac arrest

Cardiopulmonary resuscitation (CPR) guidelines recommend using TTE as a diagnostic tool during cardiorespiratory arrest (CA) to identify potentially reversible causes such as pneumothorax, cardiac tamponade, pulmonary thromboembolism, ischemic heart disease, or severe hypovolemia.45,46

TEE offers significant advantages during CPR because it provides real-time imaging without interrupting chest compressions. This facilitates identifying cardiac rhythm recovery and allows for optimized ECMO cannulation when indicated.47,48 Recent studies have shown that the area of maximum cardiac compression is not always located at the center of the thorax. The use of TEE allows for the precise targeting of compression maneuvers, thus increasing their efficacy.49

The use of echocardiography during CA has been shown to improve the prognosis, as it allows for continuous cardiac rhythm monitoring, detection of fine ventricular fibrillation, identification of intracardiac thrombi or pericardial effusion, and assessment of right and left ventricular function.50 Additionally, echocardiography is useful for differentiating between pulseless electrical activity (PEA), which is characterized by the absence of myocardial contraction, and pseudo-PEA, which is characterized by visible myocardial contraction despite the absence of a palpable pulse or effective arterial pressure. The recommended imaging planes during CPR are described in Table 4.

Table 4.

Echocardiographic study views during cardiopulmonary resuscitation.

TEE window  Cardiac structures  Applications 
ME-4C 
  • Evaluation of all cardiac cavities

  • Pericardial

  • Evaluation of mitral and tricuspid valve

 
  • Assess cardiac activity

  • Biventricular size and function

  • Fine VF detection

  • Tamponade detection

  • Identify intracardiac thrombus

 
ME-LAX 
  • Cavities LA, LV, RV, LVOT, aortic root

  • Mitral and aortic valve

 
  • Identify aortic dissection

  • Determine area of maximum compression during CPR

 
TG-SAX PM 
  • Walls of LV and IVS

 
  • Assess cardiac activity

  • Tamponade detection

  • LV/VDsize and function

 
ME-Bicava 
  • IVC, SVC, RA

 
  • Guide invasive procedure (ECMO, CVC)

  • Evaluate preload/dependence

 
ME-DescAo SAX 
  • Descending aorta

 
  • ECMO guide

 

RA: right atrium; LA: left atrium; CVC: central venous catheter; ECMO: extracorporeal membrane oxygenation; TEE: transesophageal echocardiography; VF: ventricular fibrillation; ME-4C: mid-esophageal 4-chamber; ME-DescAo SAX: mid-esophageal descending thoracic aorta short axis; ME-LAX: mid-esophageal long axis; CPR: cardiopulmonary resuscitation; IVS: interventricular septum; TG-SAX: transgastric short axis; LVOT: left ventricular outflow tract; IVC: inferior vena cava; SVC: superior vena cava; RV: right ventricle; LV: left ventricle.

Monitoring in the postoperative period of cardiac surgery

TEE is an essential diagnostic tool during cardiac surgery51,52 and also in the immediate postoperative period.53 Its intraoperative use can contribute to improved clinical outcomes,54 and the technique can effectively complement postoperative hemodynamic assessment when used in conjunction with other monitoring systems.55

In the postoperative context of cardiac surgery, TEE’s main value lies in its ability to provide an immediate, accurate, and often conclusive hemodynamic and etiological assessment for clinical decision-making.

During hemodynamic evaluation, TEE allows visualization of ventricular function and interdependence (septal position, ejection fraction, and/or shortening fraction in ME-4C and TG-SAX PM), the estimation of stroke volume and volemia status, as described above, and detection of LVOT obstructions or dynamic gradients (ME-LAX or dTG-5C).

Regarding etiological evaluation or the assessment of possible complications, TEE can detect the presence of right ventricular dysfunction56 and segmental contractility alterations (ME-4C, ME-MC, ME-LAX, and TG-SAX PM), particularly in coronary revascularization surgery. TEE can also detect the presence of pericardial effusion (Appendix B Video 2) with or without evidence of tamponade (ME-4C, ME-LAX and TG-SAX PM), and signs of prosthetic dysfunction or dehiscence (Appendix B Videos 3 and 4) (Table 5).53

Table 5.

Structures and evaluation parameters in the ECMO patient with transesophageal echocardiography.

Structure  Parameter  View  Phase 
Left ventricleMyocardial size and thickness  ME-4CPre-implantation
Septal position 
Presence of echocontrast/thrombi 
Ejection fraction  TG-SAX PMAssist
Segmental mobility 
  • Morphology

  • Systolic function

  • Diastolic function

Mitral S-wave (TDI)  dTG-5CWithdrawal
Speed and magnitude VTI of LVOT 
E/A ratio of transmitral flow 
TDE of mitral flow  ME-4CPost-implantation
E/e' ratio of mitral annulus 
Mitral and aortic valvesDiagnosis and quantification of insufficiency and/or stenosisME-4C  Pre-implantation
ME-2C 
ME-MC  Assist
ME-LAX 
Left atriumSize and volumeME-4C/ME-2C  Assist
ME-MC 
Pulmonary vein flow  ME-LAX 
Right ventricleRatio ofRV/ LV end-diastolic area  ME-4CPre-implantation
Septal position and movement 
Ventricular geometry 
Eccentricity index 
Myocardial thickness 
TAPSE  TG-SAX PMAssist
Tricuspid S' wave (TDI) 
Shortening fraction 
McConnell's sign 
Tricuspid flow E/A ratio 
  • Morphology

  • Systolic function

  • Diastolic function

  TG-5C  Withdrawal 
  ME-4C  Post-implantation 
Tricuspid and pulmonary valvesTricuspid insufficiency for sPAP estimationME RV In-OutPre-implantation 
Assist 
Right atriumArea  ME-4CPre-implantation
Structures (valves, Chiari, coronary sinus) 
Septal integrity (foramen ovale)  ME RV In-Out  Assist 
RA-LA shunt (color doppler ± shaken serum test)  ME-Bicava  Post-implantation 
Inferior/superior vena cavaSize and respiratory variation  ME-BicavaPre-implantation 
Position of cannulas  Assist 
Thrombi  Post-implantation 
AortaThrombosis/atheromatosis/dissectionME-LAX  Pre-implantation 
ME-DesAo SAXAssist 
Post-implantation 
Pericardium/pleuraEffusion (characteristics and grade)ME-4C  Assist
ME-2C 
ME-LAX  Post-implantation
TG-SAX PM 

ECMO: extracorporeal membrane oxygenation; VTI: velocity-time integral; LVOT: left ventricular outflow tract; RV: right ventricle; LV: left ventricle.

Extracorporeal membrane oxygenation and ventricular assist

ECMO and ventricular assist devices (VADs) have become established tools in cardiac intensive care medicine.57 They are essential in cases of severe heart and/or respiratory failure, in which TEE is a critical diagnostic technique.25,58,59

In the case of veno-arterial (VA) ECMO in particular, where many conventional hemodynamic monitoring systems are not validated, TEE has become consolidated as the cornerstone for patient evaluation and follow-up.60–63 TEE enables immediate assessment at the patient’s bedside, with a high diagnostic capacity. However, its correct use requires the intervention of adequately trained professionals with specific experience in this clinical context.64,65

Using a systematic exploration protocol allows TEE to assess the anatomy and function of the cardiopulmonary system before implantation. It also guides the insertion and proper positioning of the cannulas, optimizes circulatory flow according to the clinical conditions, performs dynamic monitoring to detect complications or hemodynamic changes, supervises support removal, and evaluates the heart’s structural and functional state after removal (Fig. 6) (Table 5).62,63,66,67

Figure 6.

Role of TEE in the critically ill patient with ECMO. gr6.

TEE is useful for a wide range of diagnoses, including patient-related aspects and the technique employed.68 It has proven effective in multiple scenarios, including implantation in patients with SARS-CoV-2 infection,69 situations of refractory CA oriented to the use of ECMO,70 or as a guide for specific ECMO configurations, the insertion of other devices, and the performance of invasive procedures.68,69,71,72

Cardiac evaluation as a source of systemic embolism

In patients with stroke, it is essential to investigate a possible cardiac cause as the source of cerebral embolism.73 The presence of intracardiac thrombi in the left atrium and appendage should be excluded in the ME-2C view, especially in patients with atrial fibrillation or atrial dysfunction, and in the LV in patients with ischemic heart disease or dilated cardiomyopathy. However, the LV apex is best analyzed with TTE. As previously described, the presence of PFO should be evaluated, especially in patients under 60 years of age with cryptogenic stroke.74 Similarly, the heart valves must be carefully assessed in all planes to rule out signs of endocarditis (Appendix B Video 5) and the presence of intracardiac tumors. Finally, it is advisable to complete the study by exploring the ascending aorta and aortic arch to detect ulcerated or mobile plaques measuring more than 3 mm in size.75,76

Conclusions

TEE is a valuable tool for evaluating critically ill patients. It can be used for diagnosis, hemodynamic monitoring, and performing invasive procedures. This technique goes beyond cardiac assessment to also include the pulmonary parenchyma and abdominal vein flow. It becomes an extension of the patient’s daily clinical examination. Continuous training and competency assessment of intensivists are essential to optimize performance and prevent complications.

CRediT authorship contribution statement

VFG, DPT, LMV, LZ, and AO designed the study, reviewed the literature, drafted the manuscript, participated in the design of the tables and in the recording of the figures, and reviewed the final version of the manuscript. VFG, DPT, LMV, LZ, and AO participated in the design of the tables and in the recording of the figures. VFG, DPT, LMV, LZ, and AO reviewed the final version of the manuscript. All authors read and approved the final manuscript.

Declaration of Generative AI and AI-assisted technologies in the writing process

No artificial intelligence tools were used in the drafting of the manuscript or the creation of the tables and figures. Several databases were used for the literature search, mainly PubMed. For insertion of the literature citations, the Mendeley reference manager has been used, numbering and citing the different manuscripts analyzed for the writing of the article.

Financial support

The authors declare that they have not received funding for this work.

Declaration of competing interest

The authors declare that they have no conflicts of interest.

Appendix A
Supplementary data

The following are Supplementary data to this article:

References
[1]
A. Ochagavía, V. Fraile, L. Zapata.
Introduction to the update series: update in intensive care medicine: ultrasound in the critically ill patient.
Med Intensiv Med Intensiv, 47 (2023), pp. 526-528
[2]
A. Vieillard-Baron, P.H. Mayo, P. Vignon, B. Cholley, M. Slama, M.R. Pinsky, et al.
International consensus statement on training standards for advanced critical care echocardiography.
Intensive Care Med, 40 (2014), pp. 654-666
[3]
C. Charron, P. Vignon, G. Prat, A. Tonnelier, P. Aegerter, J.M. Boles, et al.
Number of supervised studies required to reach competence in advanced critical care transesophageal echocardiography.
Intensive Care Med, 39 (2013), pp. 1019-1024
[4]
P.H. Mayo, M. Narasimhan, S. Koenig.
Critical care transesophageal echocardiography.
Chest, 148 (2015), pp. 1323-1332
[5]
G. Prat, C. Charron, X. Repesse, P. Coriat, P. Bailly, E. L’her, et al.
The use of computerized echocardiographic simulation improves the learning curve for transesophageal hemodynamic assessment in critically ill patients.
Ann Intensive Care, 6 (2016), pp. 27
[6]
J.C. Grotberg, R.K. McDonald, I.N. Co.
Point-of-care echocardiography in the difficult-to-image patient in the ICU: a narrative review.
Crit Care Explor, 6 (2024),
[7]
A. Jaidka, H. Hobbs, S. Koenig, S.J. Millington, R.T. Arntfield.
Better with ultrasound: transesophageal echocardiography.
[8]
P. Vignon, T.M. Merz, A. Vieillard-Baron.
Ten reasons for performing hemodynamic monitoring using transesophageal echocardiography.
Intensive Care Med, 43 (2017), pp. 1048-1051
[9]
R. Arntfield, V. Lau, Y. Landry, F. Priestap, I. Ball.
Impact of critical care transesophageal echocardiography in medical–surgical ICU patients: characteristics and results from 274 consecutive examinations.
J Intensive Care Med, 35 (2020), pp. 896-902
[10]
J.I. Poelaert, J. Trouerbach, M. De Buyzere, J. Everaert, F.A. Colardyn.
Evaluation of transesophageal echocardiography as a diagnostic and therapeutic aid in a critical care setting.
Chest, 107 (1995), pp. 774-779
[11]
Y.A. Garcia, L. Quintero, K. Singh, V. Lakticova, A.M. Iakovou, S.J. Koenig, et al.
Feasibility, safety, and utility of advanced critical care transesophageal echocardiography performed by pulmonary/critical care fellows in a medical ICU.
[12]
V. Lau, F. Priestap, Y. Landry, I. Ball, R. Arntfield.
Diagnostic accuracy of critical care transesophageal echocardiography vs cardiology-led echocardiography in ICU patients.
[13]
C.H. Papadopoulos, N.P.E. Kadoglou, A. Theodosis-Georgilas, I. Karabinos, S. Loizos, K.G. Papadopoulos, et al.
Transoesophageal echocardiography beyond the echo-laboratory. An expert consensus paper of the working group of echocardiography of the hellenic society of cardiology.
Hell J Cardiol, 80 (2024), pp. 64-82
[14]
F. Teran, T. Diederich, C.G. Owyang, J.A. Stancati, D.M. Dudzinski, R. Panchamia, et al.
Resuscitative transesophageal echocardiography in critical care.
J Intensive Care Med, 40 (2025), pp. 1133-1142
[15]
R.T. Hahn, T. Abraham, M.S. Adams, C.J. Bruce, K.E. Glas, R.M. Lang, et al.
Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the american society of echocardiography and the society of cardiovascular anesthesiologists.
J Am Soc Echocardiogr, 26 (2013), pp. 921-964
[16]
J.N. Hilberath, D.A. Oakes, S.K. Shernan, B.E. Bulwer, M.N. D’Ambra, H.K. Eltzschig.
Safety of transesophageal echocardiography.
J Am Soc Echocardiogr, 23 (2010), pp. 1115-1127
[17]
Y. Hirabayashi.
GlideScope-assisted insertion of a transesophageal echocardiography probe.
J Cardiothorac Vasc Anesth, 21 (2007), pp. 628
[18]
M. Taboada, A. Cariñena, A. Estany-Gestal, D. Iglesias-Álvarez, S. Veiras, A. Martínez, et al.
Videolaryngoscope versus conventional technique for insertion of a transesophageal echocardiography probe in intubated ICU patients (VIDLARECO trial): a randomized clinical trial.
Anaesth Crit Care Pain Med, 43 (2024),
[19]
K.C. Hung, W.T. Wang, C.H. Yu, J.Y. Wu, C.M. Lin, W.C. Liu, et al.
Efficacy and safety of videolaryngoscopes for transesophageal echocardiography probe insertion: a trial sequential meta-analysis.
PLoS One, 19 (2024),
[20]
E. Hüttemann, C. Schelenz, F. Kara, K. Chatzinikolaou, K. Reinhart.
The use and safety of transoesophageal echocardiography in the general ICU - a minireview.
Acta Anaesthesiol Scand, 48 (2004), pp. 827-836
[21]
R. Prager, J. Bowdridge, M. Pratte, J. Cheng, M.D.F. McInnes, R. Arntfield.
Indications, clinical impact, and complications of critical care transesophageal echocardiography: a scoping review.
J Intensive Care Med, 38 (2023), pp. 245-272
[22]
S.T. Reeves, A.C. Finley, N.J. Skubas, M. Swaminathan, W.S. Whitley, K.E. Glas, et al.
Basic perioperative transesophageal echocardiography examination: a consensus statement of the american society of echocardiography and the society of cardiovascular anesthesiologists.
J Am Soc Echocardiogr, 26 (2013), pp. 443-456
[23]
A. Fayad, S.K. Shillcutt.
Perioperative transesophageal echocardiography for non-cardiac surgery.
Can J Anaesth, 65 (2018), pp. 381-398
[24]
R. Prager, C. Ainsworth, R. Arntfield.
Critical care transesophageal echocardiography for the resuscitation of shock: an important diagnostic skill for the modern intensivist.
[25]
A. Ochagavía, N. Palomo-López, V. Fraile, L. Zapata.
Hemodynamic monitoring and echocardiographic evaluation in cardiogenic shock.
Med Intensiva, 48 (2024), pp. 602-613
[26]
G. Théry, V. Gascon, V. Fraile, A. Ochagavia, O. Hamzaoui.
How to use echocardiography to manage patients with shock?.
Med Intensiva, 48 (2024), pp. 220-230
[27]
O. Hunsicker, F. Sanfilippo, P.R. Tuinman.
How we use ultrasound to support clinical decisions on fluid administration in critical ill patients.
Intensive Care Med, 51 (2025), pp. 2131-2134
[28]
M. Slama, H. Masson, J.L. Teboul, M.L. Arnout, D. Susic, E. Frohlich, et al.
Respiratory variations of aortic VTI: a new index of hypovolemia and fluid responsiveness.
Am J Physiol Heart Circ Physiol, 283 (2002), pp. 1729-1733
[29]
M. Feissel, F. Michard, I. Mangin, O. Ruyer, J.P. Faller, J.L. Teboul.
Respiratory changes in aortic blood velocity as an indicator of fluid responsiveness in ventilated patients with septic shock.
Chest, 119 (2001), pp. 867-873
[30]
Z. Cheng, Q. Yang, P. Zhu, J. Feng, X. Zhang, Z. Zhao.
Transesophageal echocardiographic measurements of the superior vena cava for predicting fluid responsiveness in patients undergoing invasive positive pressure ventilation.
J Ultrasound Med, 38 (2019), pp. 1519-1525
[31]
T. Krolicki, M. Molsa, A. Tukiendorf, R. Gawda, T. Czarnik.
Superior vena cava collapsibility index as a predictor of fluid responsiveness: a systematic review with meta-analysis.
Anaesthesiol Intensive Ther, 56 (2024), pp. 169-176
[32]
P. Vignon, X. Repessé, E. Begot, J. Léger, C. Jacob, K. Bouferrache, et al.
Comparison of echocardiographic indices used to predict fluid responsiveness in ventilated patients.
Am J Respir Crit Care Med, 195 (2017), pp. 1022-1032
[33]
A. Vieillard-Baron, K. Chergui, A. Rabiller, O. Peyrouset, B. Page, A. Beauchet, et al.
Superior vena caval collapsibility as a gauge of volume status in ventilated septic patients.
Intensive Care Med, 30 (2004), pp. 1734-1739
[34]
Y. Li, L. Jiang, L. Wang, D. Dou, Y. Feng.
Evaluation of fluid responsiveness with dynamic superior vena cava collapsibility index in mechanically ventilated patients.
Perioper Med (Lond), 12 (2023), pp. 10
[35]
ŞI. Bubenek-Turconi, A. Hendy, S. Băilă, A. Drăgan, O. Chioncel, L. Văleanu, et al.
The value of a superior vena cava collapsibility index measured with a miniaturized transoesophageal monoplane continuous echocardiography probe to predict fluid responsiveness compared to stroke volume variations in open major vascular surgery: a prospective cohort study.
J Clin Monit Comput, 34 (2020), pp. 491-499
[36]
L. Galarza Barrachina, L. Colinas Fernández, R. Martín Bermúdez, A. Fernández Galilea, L. Martín-Villén.
Abdominal ultrasound and VExUS score in critical care.
Med Intensiva, 47 (2023), pp. 658-667
[37]
N.H. Waldron, G. Pandompatam, B. Sareyyupoglu, H. Kalagara.
Transesophageal echocardiographic acquisition of the venous excess ultrasound exam-a case series and technical description.
Can J Anaesth, 71 (2024), pp. 422-430
[38]
A. Mekontso Dessap, F. Boissier, R. Leon, S. Carreira, F. Roche Campo, F. Lemaire, et al.
Prevalence and prognosis of shunting across patent foramen ovale during acute respiratory distress syndrome.
Crit Care Med, 38 (2010), pp. 1786-1792
[39]
J.K. Song.
Pearls and pitfalls in the transesophageal echocardiographic diagnosis of patent foramen ovale.
J Am Soc Echocardiogr, 36 (2023), pp. 895-905.e3
[40]
P. Pruszczyk, A. Kuch-Wocial, M. Szulc, A. Torbicki, R. Pacho.
Diagnostic value of transoesophageal echocardiography in suspected haemodynamically significant pulmonary embolism.
Heart, 85 (2001), pp. 628-634
[41]
V. Fraile-Gutiérrez, L. Zapata-Fenor, A. Blandino-Ortiz, M. Guerrero-Mier, A. Ochagavia-Calvo.
Right ventricular dysfunction in the critically ill. Echocardiographic evaluation.
Med Intensiva (Engl Ed), 48 (2024), pp. 528-542
[42]
A.G. Weber, F. Mastroianni, S. Koenig, P.H. Mayo.
Transesophageal lung ultrasonography as part of the critical care transesophageal echocardiography examination.
Chest, 161 (2022), pp. e335-6
[43]
D. Cao, W. Song, W. Zhu, T. Yang, X. Ma, H. Yuan, et al.
Transesophageal lung ultrasound score is associated with arterial oxygenation and clinical outcomes in mechanically ventilated critically ill patients.
Intensive Care Med Exp, 13 (2025), pp. 107
[44]
D.A.R. Serrano, P.P. Terán, R. Blancas, M. Arroyo.
Pleuropulmonary and diaphragmatic ultrasound in intensive care medicine.
Med Intensiva, 47 (2023), pp. 594-602
[45]
J.P. Nolan, C. Sandroni, B.W. Böttiger, A. Cariou, T. Cronberg, H. Friberg, et al.
European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: post-resuscitation care.
Resuscitation, 161 (2021), pp. 220-269
[46]
J.P. Nolan, C. Sandroni, A. Cariou, T. Cronberg, S. D’Arrigo, K. Haywood, et al.
European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2025: post-resuscitation care.
Intensive Care Med, 51 (2025), pp. 2213-2288
[47]
J. Fair, J. Tonna, P. Ockerse, B. Galovic, S. Youngquist, S.H. McKellar, et al.
Emergency physician–performed transesophageal echocardiography for extracorporeal life support vascular cannula placement.
Am J Emerg Med, 34 (2016), pp. 1637-1639
[48]
F. Teran, A.J. Dean, C. Centeno, N.L. Panebianco, A.J. Zeidan, W. Chan, et al.
Evaluation of out-of-hospital cardiac arrest using transesophageal echocardiography in the emergency department.
Resuscitation, 137 (2019), pp. 140-147
[49]
S. Nestaas, K.H. Stensæth, V. Rosseland, J. Kramer-Johansen.
Radiological assessment of chest compression point and achievable compression depth in cardiac patients.
Scand J Trauma Resusc Emerg Med, 24 (2016), pp. 54
[50]
S.G. Memtsoudis, P. Rosenberger, M. Loffler, H.K. Eltzschig, A. Mizuguchi, S.K. Shernan, et al.
The usefulness of transesophageal echocardiography during intraoperative cardiac arrest in noncardiac surgery.
Anesth Analg, 102 (2006), pp. 1653-1657
[51]
A. Nicoara, N. Skubas, N. Ad, A. Finley, R.T. Hahn, F. Mahmood, et al.
Guidelines for the use of transesophageal echocardiography to assist with surgical decision-making in the operating room: a surgery-based approach: from the American Society of Echocardiography in Collaboration with the Society of Cardiovascular Anesthesiologists and the Society of Thoracic Surgeons.
J Am Soc Echocardiogr, 33 (2020), pp. 692-734
[52]
Y. Dimitroglou, A. Karanasos, A. Katsaros, A. Kalompatsou, G. Tsigkas, K. Toutouzas, et al.
Intraoperative transesophageal echocardiographic guidance in cardiac surgery.
J Cardiovasc Dev Dis, 12 (2025), pp. 93
[53]
A. Carrillo López, C. Llanos Jorge, J.J. Jiménez Rivera, F. Clau-Terre.
Ecografía en el postoperatorio de cirugía cardíaca.
Med Intensiva, 48 (2024), pp. 103-119
[54]
E.J. MacKay, M.D. Neuman, L.A. Fleisher, P.A. Patel, J.T. Gutsche, J.G. Augoustides, et al.
Transesophageal echocardiography, mortality, and length of hospitalization after cardiac valve surgery.
J Am Soc Echocardiogr, 33 (2020), pp. 756-762.e1
[55]
N. Bahatyrevich, Q. Yang, N.C. Cavarocchi, H. Hirose.
Is hemodynamic transesophageal echocardiography needed for patients with left ventricular assist device?.
J Thorac Cardiovasc Surg, 155 (2018), pp. 1071-1077
[56]
F. Haddad, R. Doyle, D.J. Murphy, S.A. Hunt.
Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure.
Circulation, 117 (2008), pp. 1717-1731
[57]
J.C. Jentzer, A.M. Ahmed, S. Vallabhajosyula, B. Burstein, M. Tabi, G.W. Barsness, et al.
Shock in the cardiac intensive care unit: changes in epidemiology and prognosis over time.
Am Heart J, 232 (2021), pp. 94-104
[58]
M.S. Chew, N. Aissaoui, M. Balik.
Echocardiography in shock.
Curr Opin Crit Care, 29 (2023), pp. 252-258
[59]
T.J. Vandyck, M.R. Pinsky.
Hemodynamic monitoring in cardiogenic shock.
Curr Opin Crit Care, 27 (2021), pp. 454-459
[60]
C. Vandenbriele, L. Baldetti, A. Beneduce, J. Belohlavek, C. Hassager, M. Pieri, et al.
Monitoring MCS patients on the intensive care unit: Integrating haemodynamic assessment, laboratory data, and imaging techniques for timely detection of deterioration and recovery.
Eur Heart J Suppl, 25 (2023), pp. 124-134
[61]
M. Cameli, H.S. Aboumarie, M.C. Pastore, K. Caliskan, M. Cikes, M. Garbi, et al.
Multimodality imaging for the evaluation and management of patients with long-term (durable) left ventricular assist devices.
Eur Heart J Cardiovasc Imaging, 25 (2024), pp. e217-40
[62]
G. Douflé, L. Dragoi, D. Morales Castro, K. Sato, D.W. Donker, N. Aissaoui, et al.
Head-to-toe bedside ultrasound for adult patients on extracorporeal membrane oxygenation.
Intensive Care Med, 50 (2024), pp. 632-645
[63]
L. Martin-Villen, R. Martin-Bermudez, H. Perez-Chomon, M.P. Fuset Cabanes.
Role of ultrasound in the critical ill patient with ECMO.
Med Intensiva, 48 (2024), pp. 46-55
[64]
W. Julliard, N. Teman.
Extracorporeal membrane oxygenation: how i teach it.
Ann Thorac Surg, 109 (2020), pp. 325-328
[65]
D. Abrams, A.R. Garan, A. Abdelbary, M. Bacchetta, R.H. Bartlett, J. Beck, et al.
Position paper for the organization of ECMO programs for cardiac failure in adults.
Intensive Care Med, 44 (2018), pp. 717-729
[66]
G. Douflé, A. Roscoe, F. Billia, E. Fan.
Echocardiography for adult patients supported with extracorporeal membrane oxygenation.
[67]
P.T. Hussey, G. von Mering, N.C. Nanda, M.I. Ahmed, D.R. Addis.
Echocardiography for extracorporeal membrane oxygenation.
Echocardiography, 39 (2022), pp. 339-370
[68]
G. Tavazzi, S. Price, J.O. Beitnes, C. Bleakley, M. Balik, S. Lochy, et al.
Imaging in acute percutaneous mechanical circulatory support in adults: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Cardiovascular Imaging (EACVI) of the ESC and the European branch of the Extracorporeal Life Support Organization (EuroELSO).
Eur Heart J Cardiovasc Imaging, 25 (2024), pp. e296-311
[69]
D. Morales Castro, E. Abdelnour-Berchtold, M. Urner, L. Dragoi, M. Cypel, E. Fan, et al.
Transesophageal echocardiography-guided extracorporeal membrane oxygenation cannulation in COVID-19 patients.
J Cardiothorac Vasc Anesth, 36 (2022), pp. 4296-4304
[70]
T. Rosseel, T. Van Puyvelde, J.U. Voigt, D. Dauwe, B. Meyns, P. Dewolf, et al.
How to perform focused transoesophageal echocardiography during extracorporeal cardiopulmonary resuscitation?.
Eur Heart J Cardiovasc Imaging, 24 (2023), pp. 12-14
[71]
S.P. Cole, N. Martinez-Acero, A. Peterson, P. Von Homeyer, B. Gebhardt, A. Nicoara.
Imaging for temporary mechanical circulatory support devices.
J Cardiothorac Vasc Anesth, 36 (2022), pp. 2114-2131
[72]
J. Crowley, B. Cronin, M. Essandoh, D. D’Alessandro, K. Shelton, A.A. Dalia.
Transesophageal echocardiography for impella placement and management.
J Cardiothorac Vasc Anesth, 33 (2019), pp. 2663-2668
[73]
S.F. Arnautu, D.A. Arnautu, A. Lascu, A.A. Hajevschi, C.I. Rosca, A. Sharma, et al.
A review of the role of transthoracic and transesophageal echocardiography, computed tomography, and magnetic resonance imaging in cardioembolic stroke.
Med Sci Monit, 28 (2022),
[74]
E. Canali, M. Serani, P. Tarzia, P. Ciampi, S. Canestrelli, L. Calò.
Echocardiography in cardioembolic stroke prevention.
Eur Heart J Suppl, 25 (2023), pp. C212-C217
[75]
L.P. Pallesen, M. Ragaller, J. Kepplinger, K. Barlinn, C. Zerna, T. Siepmann, et al.
Diagnostic impact of transesophageal echocardiography in patients with acute cerebral ischemia.
Echocardiography, 33 (2016), pp. 555-561
[76]
G. Thomalla, M. Upneja, S. Camen, M. Jensen, J. Schröder, E. Barow, et al.
Treatment-relevant findings in transesophageal echocardiography after stroke: a prospective multicenter cohort study.
Copyright © 2026. Elsevier España, S.L.U. and SEMICYUC
Download PDF
Idiomas
Medicina Intensiva (English Edition)
Article options
Tools
Supplemental materials